Suppr超能文献

160千道尔顿核受体辅激活蛋白的多个信号输入和输出结构域。

Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins.

作者信息

Ma H, Hong H, Huang S M, Irvine R A, Webb P, Kushner P J, Coetzee G A, Stallcup M R

机构信息

Departments of Pathology, University of Southern California, Los Angeles, California 90033, USA.

出版信息

Mol Cell Biol. 1999 Sep;19(9):6164-73. doi: 10.1128/MCB.19.9.6164.

Abstract

Members of the 160-kDa nuclear receptor coactivator family (p160 coactivators) bind to the conserved AF-2 activation function found in the hormone binding domains of nuclear receptors (NR) and are potent transcriptional coactivators for NRs. Here we report that the C-terminal region of p160 coactivators glucocorticoid receptor interacting protein 1 (GRIP1), steroid receptor coactivator 1 (SRC-1a), and SRC-1e binds the N-terminal AF-1 activation function of the androgen receptor (AR), and p160 coactivators can thereby enhance transcriptional activation by AR. While they all interact efficiently with AR AF-1, these same coactivators have vastly different binding strengths with and coactivator effects on AR AF-2. p160 activation domain AD1, which binds secondary coactivators CREB binding protein (CBP) and p300, was previously implicated as the principal domain for transmitting the activating signal to the transcription machinery. We identified a new highly conserved motif in the AD1 region which is important for CBP/p300 binding. Deletion of AD1 only partially reduced p160 coactivator function, due to signaling through AD2, another activation domain located at the C-terminal end of p160 coactivators. C-terminal coactivator fragments lacking AD1 but containing AD2 and the AR AF-1 binding site served as efficient coactivators for full-length AR and AR AF-1. The two signal input domains (one that binds NR AF-2 domains and one that binds AF-1 domains of some but not all NRs) and the two signal output domains (AD1 and AD2) of p160 coactivators played different relative roles for two different NRs: AR and thyroid hormone receptor.

摘要

160 kDa核受体共激活因子家族(p160共激活因子)的成员与核受体(NR)激素结合域中保守的AF-2激活功能结合,是NRs强大的转录共激活因子。在此我们报告,p160共激活因子糖皮质激素受体相互作用蛋白1(GRIP1)、类固醇受体共激活因子1(SRC-1a)和SRC-1e的C末端区域与雄激素受体(AR)的N末端AF-1激活功能结合,因此p160共激活因子可增强AR的转录激活作用。虽然它们都能与AR AF-1高效相互作用,但这些相同的共激活因子与AR AF-2的结合强度和共激活作用却有很大差异。与二级共激活因子CREB结合蛋白(CBP)和p300结合的p160激活域AD1,先前被认为是将激活信号传递给转录机制的主要结构域。我们在AD1区域鉴定出一个新的高度保守基序,它对CBP/p300结合很重要。由于通过位于p160共激活因子C末端的另一个激活域AD2进行信号传导,AD1的缺失仅部分降低了p160共激活因子的功能。缺乏AD1但含有AD2和AR AF-1结合位点的C末端共激活因子片段可作为全长AR和AR AF-1的有效共激活因子。p160共激活因子的两个信号输入域(一个结合NR AF-2结构域,另一个结合部分但不是所有NRs的AF-1结构域)和两个信号输出域(AD1和AD2)在两种不同的NRs:AR和甲状腺激素受体中发挥了不同的相对作用。

相似文献

2
Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300.
J Biol Chem. 2000 Dec 29;275(52):40810-6. doi: 10.1074/jbc.M005459200.
8
Developmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activity.
Mol Cell Biol. 2004 Mar;24(5):2103-17. doi: 10.1128/MCB.24.5.2103-2117.2004.
9
P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.
Nucleic Acids Res. 2008 Apr;36(6):1847-60. doi: 10.1093/nar/gkn029. Epub 2008 Feb 11.
10
Regulation of transcription by a protein methyltransferase.
Science. 1999 Jun 25;284(5423):2174-7. doi: 10.1126/science.284.5423.2174.

引用本文的文献

1
Insulin-Induced AKR1C3 Induces Fatty Acid Synthase in a Model of Human PCOS Adipocytes.
Endocrinology. 2023 Mar 13;164(5). doi: 10.1210/endocr/bqad033.
2
Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP.
Eur J Med Chem. 2022 Jul 5;237:114407. doi: 10.1016/j.ejmech.2022.114407. Epub 2022 Apr 27.
4
Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer.
Front Mol Biosci. 2021 Dec 15;8:743376. doi: 10.3389/fmolb.2021.743376. eCollection 2021.
5
6
Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor.
Assay Drug Dev Technol. 2019 Nov/Dec;17(8):364-386. doi: 10.1089/adt.2019.940. Epub 2019 Sep 6.
7
Metabolic Dysregulation Controls Endocrine Therapy-Resistant Cancer Recurrence and Metastasis.
Endocrinology. 2019 Aug 1;160(8):1811-1820. doi: 10.1210/en.2019-00097.
8
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.
Cancer Cell. 2019 Mar 18;35(3):401-413.e6. doi: 10.1016/j.ccell.2019.01.008. Epub 2019 Feb 14.

本文引用的文献

2
Regulation of transcription by a protein methyltransferase.
Science. 1999 Jun 25;284(5423):2174-7. doi: 10.1126/science.284.5423.2174.
4
Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation.
Genes Dev. 1998 Nov 1;12(21):3357-68. doi: 10.1101/gad.12.21.3357.
5
Structure and specificity of nuclear receptor-coactivator interactions.
Genes Dev. 1998 Nov 1;12(21):3343-56. doi: 10.1101/gad.12.21.3343.
6
Estrogen receptor activation function 1 works by binding p160 coactivator proteins.
Mol Endocrinol. 1998 Oct;12(10):1605-18. doi: 10.1210/mend.12.10.0185.
8
Going the distance: a current view of enhancer action.
Science. 1998 Jul 3;281(5373):60-3. doi: 10.1126/science.281.5373.60.
9
The TAFs in the HAT.
Cell. 1998 Jul 10;94(1):1-4. doi: 10.1016/s0092-8674(00)81213-1.
10
Co-activators and co-repressors in the integration of transcriptional responses.
Curr Opin Cell Biol. 1998 Jun;10(3):373-83. doi: 10.1016/s0955-0674(98)80014-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验